Evaluation of Urine Samples and Their Relation to Urinary Tract Infection
NCT ID: NCT03522766
Last Updated: 2020-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2018-03-19
2019-09-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Diagnostic Tools in Patients With a Suspected Urinary Tract Infection in Primary Care
NCT02249273
Evaluating UTI Outcomes in at Risk Populations
NCT05385536
Effect of a Diagnostic Algorithm for Urinary Tract Infection in General Practice
NCT02698332
Diagnostic Accuracy of Urine Flow Cytometry in Excluding Bacteruria
NCT04686292
The Impact of De-implementing Urine Dipsticks for Diagnosis of UTIs in Hospitals
NCT06750666
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy volunteers with no urinary tract infections
people who don't experience urinary tract infections
urine sample
The subjects are asked to give a maximum of 15 urine samples during the study
Healthy volunteers with urinary tract infections
people who frequently experience urinary tract infections
urine sample
The subjects are asked to give a maximum of 15 urine samples during the study
Intermittent catheter users with neurogenic bladder
urine sample
The subjects are asked to give a maximum of 15 urine samples during the study
Intermittent catheter users with enlarged prostate
urine sample
The subjects are asked to give a maximum of 15 urine samples during the study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
urine sample
The subjects are asked to give a maximum of 15 urine samples during the study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Be at least 18 years of age and have full legal capacity
3. For the 2 patient populations: Use intermittent catheter on a daily basis due to neurogenic bladder or enlarged prostate and have used IC for at least 2 months
4. For healthy volunteers without UTIs: No diag-nosed UTIs within the last year
5. For healthy volunteers with recurrent UTIs: 3 or more UTIs within the last year or 2 UTIs within the last 6 months (treated with antibiotics)
Exclusion Criteria
2. May not take prophylactic treatment for urinary tract infections (antibiotics only)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Coloplast A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lene F Nielsen, PhD
Role: PRINCIPAL_INVESTIGATOR
Coloplast A/S
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Coloplast A/S
Humlebæk, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP287
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.